Alzheimer's Disease Drug Development

Explore the intricate world of Alzheimer's disease drug development with Alzheimer's Disease Drug Development by Jeffrey Cummings. Published by Cambridge University Press in 2022, this comprehensive hardback edition spans 574 pages and serves as an essential resource for anyone interested in the pharmaceutical landscape surrounding Alzheimer's research.

This book offers a definitive overview of the multifaceted ecosystem that drives drug research and development for Alzheimer's disease. It meticulously details the journey of a drug from laboratory inception through clinical trial testing, regulatory review, and ultimately to market launch by pharmaceutical companies. Additionally, it highlights the pivotal roles of artificial intelligence, clinical trial management, and innovative financing models in advancing this critical field.

Whether you are a healthcare professional, researcher, or simply interested in understanding the complexities of drug development, Jeffrey Cummings' insightful work is a must-read for navigating the future of Alzheimer's disease treatment.